The effects of purified recombinant interleukin 7 (IL7) on the generation of cytolytic T lymphocytes (CTL) in mixed lymphocyte culture (MLC) and on the induction oflymphokine-activated killer (LAK) cells in autologous cultures of human peripheral blood mononuclear cells were investigated . IL7 was found to induce the generation ofboth CTL and LAK cells in bulk cultures. The appearance of peak CTL activity in MLC established with exogenous IL-7 was delayed in comparison with replicate cultures containing exogenous IL2, but both cytokines stimulated quantitatively similar levels of antigen-specific lytic activity. An IL2-neutralizing antiserum inhibited substantially, but not completely, the effect of IL7 on CTL generation, implying the existence of both an indirect component of 11,7 activity via IL2 utilization, as well as an IL2-independent component. Cell surface phenotypic analysis of 11,2-or IL7-generated CTL effector cells revealed that CD8+ cells were responsible for the vast majority of lytic activity. Limiting dilution analysis (LDA) revealed that essentially identical frequencies of CTL precursors (CTLP) were capable of clonal expansion and/or differentiation in the presence of exogenous IL2, 114, or IL7, supporting the concept that all three of these cytokines are capable of exerting a major influence on T cell growth and differentiation . Approximately half of the CTLP that responded in IL7-supplemented LDA cultures did so in an IL2-independent manner. IL7 stimulated the development of LAK cells in autologous bulk cultures, but only weakly in comparison with IL2. In contrast to its effects on CTL generation, the induction of LAK cells by 11,7 was virtually independent of IL-2. LAK cells induced by IL7, like those induced by 11,2, were phenotypically heterogeneous and included CD8+, CD56+, and -y/S+ cells . Limiting dilution analysis indicated that 1172 stimulated fivefold more LAK-P than IL7 and 220-fold more than 1174. Collectively, these data suggest that 11,7 has potent regulatory effects on human cytolytic cell populations and, either alone or in combination with other cytokines, could be important for the in vitro expansion of cells for adoptive immunotherapy.
Summary
The effects of purified recombinant interleukin 7 (IL7) on the generation of cytolytic T lymphocytes (CTL) in mixed lymphocyte culture (MLC) and on the induction oflymphokine-activated killer (LAK) cells in autologous cultures of human peripheral blood mononuclear cells were investigated . IL7 was found to induce the generation ofboth CTL and LAK cells in bulk cultures. The appearance of peak CTL activity in MLC established with exogenous IL-7 was delayed in comparison with replicate cultures containing exogenous IL2, but both cytokines stimulated quantitatively similar levels of antigen-specific lytic activity. An IL2-neutralizing antiserum inhibited substantially, but not completely, the effect of IL7 on CTL generation, implying the existence of both an indirect component of 11,7 activity via IL2 utilization, as well as an IL2-independent component. Cell surface phenotypic analysis of 11,2-or IL7-generated CTL effector cells revealed that CD8+ cells were responsible for the vast majority of lytic activity. Limiting dilution analysis (LDA) revealed that essentially identical frequencies of CTL precursors (CTLP) were capable of clonal expansion and/or differentiation in the presence of exogenous IL2, 114, or IL7, supporting the concept that all three of these cytokines are capable of exerting a major influence on T cell growth and differentiation . Approximately half of the CTLP that responded in IL7-supplemented LDA cultures did so in an IL2-independent manner. IL7 stimulated the development of LAK cells in autologous bulk cultures, but only weakly in comparison with IL2. In contrast to its effects on CTL generation, the induction of LAK cells by 11,7 was virtually independent of IL-2. LAK cells induced by IL7, like those induced by 11,2, were phenotypically heterogeneous and included CD8+, CD56+, and -y/S+ cells . Limiting dilution analysis indicated that 1172 stimulated fivefold more LAK-P than IL7 and 220-fold more than 1174. Collectively, these data suggest that 11,7 has potent regulatory effects on human cytolytic cell populations and, either alone or in combination with other cytokines, could be important for the in vitro expansion of cells for adoptive immunotherapy.
Activation of resting T lymphocytes into cytolytic cells 1-1 normally requires both interaction with processed antigen through the TCR complex and the collaborative action of soluble cytokines (1) . Among the cytokines with reputed roles in T cell proliferation and/or differentiation are IL-1, -2, -4, -5, and -6, TNF, IFN-y, and granulocyte-macrophage CSF (2) (3) (4) (5) (6) (7) (8) . The most recent addition to the list of T cell-active cytokines was IL-7. IL-7 was originally purified and its cDNA cloned based upon the ability to cause the growth of pre-B cells (9) . More recently, it has been shown to be a potent costimulus for the proliferation of mitogenactivated murine and human T cells (10-13). Notably, IL7 has been shown to expand numerically both CD4+ and CD8+ T cells. The cytokine IL-2, in addition to promoting the growth and differentiation of T cells, including CTL, also has been shown to induce a killer cell population in the absence of overt antigen that is able to lyse fresh tumor cells and NK-resistant tumor cell lines (14) . These cytolytic cells, termed lymphokine-activated killer (LAK)t cells, are also regulated in both a positive and negative manner by other cytokines, including IL-4 (15) (16) (17) (18) .
In this study, we assessed the activity of purified rIL7 on the generation of CTL from human PBL in MLC, and on the induction of LAK cells in autologous cultures, both alone and in combination with IL-2 and IL-4. Exogenous IL-7 was found to be a potent enhancer of antigen-specific CTL generation with activity equivalent to IIT2 . However, optimal lytic activity generated by IL-7 was detected later than in cultures supplemented with IL2. The effect of IL7 on the generation of CTL could be partially inhibited by antibodies against ILL 2, though there remained a portion of IL2-independent activity. IL-7 also induced LAK cells in cultures containing no overt antigenic stimulus, but did so far less efficiently than IL-2 . In contrast to the generation of CTL, the induction of LAK activity by IL-7 was not inhibited by anti-IL-2. Thus, the effects of 11,7 on the development of cytolytic cells in vitro appear to have both IL-2-dependent and IL-2-independent components, depending upon the culture system (MLC vs . autologous) and corresponding cell types (CTL vs . LAK) involved . These results implicate IL-7 as an important regulatory cytokine in human lymphocyte growth and differentiation.
Materials and Methods
Cell Cultures. PBMC were isolated from heparinized blood by centrifugation over Ficoll-Hypaque and washed three times with culture medium . Culture medium consisted of RPMI 1640 (Gibco Laboratories, Grand Island, NY) supplemented with 10% FCS (Hr clone Laboratories, Logan, UT), 50 U/ml penicillin, 50 leg/ml streptomycin, 2 mM glutamine and 5 x 10 -5 M 2-ME. 10 6 PBMC were cultured with 106 irradiated stimulating cells (3,500 rad, using a 131CS source) in 16-mm wells (3524; Costar, Cambridge, MA) in 2 ml of culture medium . Cultures were incubated at 37°C in 5% COZ for 7-14 d. The tumor cell lines Daudi and K562 were obtained from the American Type Culture Collection (Rockville, MD) and maintained in continuous passage.
Cytokines. Human rIL2 and rIL4 were purified from supernatants of yeast cells expressing thecorresponding cDNA as described previously (15, 19) . Purified IL2 had a specific activity of 3 x 105 U/Itg in the CTLL assay (20) . Purified IL-4 had a specific activity of 104 U/p,g in a B cell comitogenesis assay (15) .
A human IL-7 cDNA was cloned as previously described (21) and expressed in Escherichia coli. IL-7 was extracted from an E. coli cell paste by soaking the cells in 6 M guanidine HCl, 0.15 M sodium sulfite, 0.05 M potassium tetrathionate, 0.1 M Tris, pH 8, for 16 h at room temperature. The resulting lysate was clarified by centrifugation (30,000 g, 30 min, 20°C) and applied to a column of NTA-Sepharose (22) . The column was washed with 6 M guanidine HCI, 0.1 M Tris, pH 8, and then eluted with 6 M guanidine HCI, 1% acetic acid . The purified IL-7 was then refolded and dialyzed to 50 mM sodium phosphate, pH 7.2 . Protein concentration was determined by amino acid analysis and biological activity was determined using the murine pre-B cell assay (9) . Specific activity of IL-7 expressed in E. coli and mammalian cells was equivalent .
Cytotoxicity Assay. A 4-h "Cr release assay was used to assess cytolytic activity of cultured cells, as previously described (15) . Briefly, tumor cell lines or PBMC cultured for 3 d with PHA (PHA blasts) were radiolabeled by incubation with 100 j.Ci of "Cr for 1 h at 37°C. Cell cultures to be assessed for rytolytic activity were washed twice in culture medium and serially diluted in 96-well Vbottomed plates (3896; Costar). "Cr-labeled targets (2 x 103) were added to make a final volume of 0.2 ml/well. After 4 h at 37°C, plates were centrifuged (150 g for 5 min), and 150 Id of supernatant were harvested from each well . "Cr content of supernatants was determined using an Auto gamma counter (5780;
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Interleukin 7 Regulation of Human Cytolytic Lymphocytes Packard Instrument Co ., Downers Grove, IL). 1 LU was defined as the fraction of the initial culture giving rise to 25 or 50% lysis of the target cell population (PHA blasts and Daudi, respectively), and was determined from dose-response curves . Percent specific "Cr release was calculated according to the formula: 100x (experimental cpm -spontaneous cpm)/(maximum cpm -spontaneous cpm), where spontaneous cpm . = cpm released in the absence of effector cells and maximum cpm = cpm released in the presence of 1 N HCI. Anti-IL2 Serum. A rabbit antiserum raised against purified human rIL2 was used to neutralize IL-2 bioactivity. The antiserum was used at a 1 :500 dilution, a concentration that could totally neutralize up to 10 ng/ml of IL-2 activity.
Limiting Dilution Analysis (LDA). Limiting numbers of responding cells (ranging from 10 to 10,000 cells/well) were cultured in 24 replicates per cell concentration in 96-well round-bottomed microtiter plates (25850; Corning Glass Works, Coming, NY) with 10 5 irradiated, autologous (LAK-P analysis) or allogeneic (CTLP analysis) PBMC. After a 13-14-d incubation, the culture supernatants were removed and the cellular contents of individual wells were resuspended in 100 p,l of fresh medium . The cells were then transferred to the wells of V-bottomed plates, and 2 x 103 "Crlabeled targets in 100 td of medium were added per well . The E/T mixtures were incubated in a 4-h "Cr release assay, as described above.
Statistical Analysis. CTLP and LAK-P frequencies were determined from the Poisson distribution relationship between the number of cells per microculture and the percent cytolytically negative microcultures using the minimum Xz method, as described by Taswell (23) . Cultures were considered positive if the specific "Cr release exceeded by 3 SD the mean background "Cr release exhibited by control cultures comprised of feeder cells with cytokines but no responding cells.
Separation ofEffector Cell Subsets by Immunoadsorbent Panning. The following murine mAbs against human cell surface antigens were used for immunoadsorbent panning: OKT4 (CD4), OKTS (CD8), Leu-19 (CD56, expressed on NK cells and cytotoxic T cells that mediate non-MHC-restricted cytotoxicity ; Becton Dickinson & Co., Mountain View, CA), and TCR-61 (recognizing the S chain of the TCR; T Cell Sciences, Cambridge, MA) . Cells were suspended in 100 /.l of culture medium supplemented with 10 jig/ml of mAb at 4°C. After 30 min, cells were washed three times with PBS containing 1% FCS. Labeled cells were then incubated on plastic petri dishes that had previously been coated with goat anti-mouse IgG (Sigma Chemical Co ., St . Louis, MO) at 5 p,g/ml for 2 h. Petri dishes were incubated at 4°C for 40 min. Nonadherent cells were collected by washing gently three times with 3 ml of PBS containing 1% FCS. Adherent cells were recovered using a cell scraper and collected by washing. Isolated cell populations were assessed for purity by flow cytometry.
Results

11,7
Augments Antigen-Specific CTL Generation . Freshly isolated PBMC from human donor VB were cultured in MLC in the presence of irradiated stimulating cells from allogeneic donor KB and 10 ng/ml of either human rII,2 or human rIL7 . Cytolytic activity against PHA blasts was assessed at day 7 using a 4-h 5'Cr release assay. Culture of cells from these two donors in MLC under the conditions used in this study results in a detectable but weak CTL response that can be augmented significantly by cytokines that promote CTL development (15) . Addition of either IL2 or IL-7 at the beCell cultures were established with 106 VB effector cells and 106 irradiated VB-or KB-stimulating cells . IL-2 or IL-7 was added at 10 ng/ml, and cultures were assessed for cytolytic activity at day 7 against 5 'Cr-labeled KB or VB PHA blasts or Daudi target cells. ' Data represent LU per culture. LU were calculated from the doseresponse curves (see Figs . 1 and 2) using 25% specific 5'Cr release for KB and VB PHA blasts and 50% specific 5'Cr release for Daudi targets . The lysability of VB targets was previously established with a control KB anti-VB culture supplemented with IL-2, which exhibited >150 LU of anti-VB activity .
ginning of culture significantly enhanced the generation of cytolytic activity against KB targets prepared from the stimulating cell donor, when compared with cultures containing no exogenous cytokine ( Fig. 1) . As shown in Table  1 , anti-KB lytic activity recovered on day 7 of VB anti-KB MLC was enhanced -200-fold by inclusion of exogenous IL-2 in culture, and 60-fold by IL7 in comparison with cultures containing no exogenous cytokine. In a series of five identical experiments where VB responding cells were cultured with irradiated KB-stimulating cells and assayed for lytic activity against KB PHA blast targets at day 7-10, nonsupplemented cultures contained an average of -1 LU/culture (range, <1-2), compared with 49 LU/culture for IL-7-supplemented cultures (range, 16-88) and 115 LU/culture for IL-2-supplemented cultures (range, 28-215). In addition, CTL 579
Alderson et al .
Cell cultures were established with 106 responding cells and 106 stimulating cells. Cytokines (10 ng/ml) and cytolytic activity was tested against 5 'Cr-labeled PHA blasts on day 9. ' Results are expressed as LU per culture. VB anti-KB MLC were supplemented with 10 ng/ml of either 11,2 or IL.7 and assayed at day 7 for their ability to lyse 5 'Cr-labeled PHA blasts from donor KB in a 4-h 51Cr release assay. Cell recoveries were 92% for nonsupplemented cultures and 270 and 208%, respectively, for 11,2-and IL,7-supplemented cultures . generated in either IL-2-or IL-7-supplemented MLC were specific for KB targets in that they were unable to cause significant lysis of control VB targets syngeneic with the responding cell donor. Table 2 shows the results of an experiment with three different blood donors . In all cases, the generation of lytic activity against PHA blast target cells from the stimulating cell donor was significantly enhanced (>100-fold) by the addition of either IL2 or IL 7. As anticipated, crossreactive lytic activity against third-party targets was also enhanced by either IL-2 or 11,7, however, minimal lytic activity was observed against target cells from the, responding cell donor. 11,7 Stimulates the Formation of LAK Cells. Autologous cultures of VB PBMC containing either IL-2 or IL-7 but no overt antigen were assessed for cytolytic activity against the LAK-sensitive, NK-resistant tumor cell line Daudi. Supplementation of cultures with either IL2 or IL7 resulted in the appearance of a LAK cell population that lysed Daudi targets (Fig. 2) . However, IL-7 induced 10-20-fold less LAK activity per culture than did IL2 (Table 1) . In a series of five were added at the initiation of culture Table 3 shows data derived from a kinetics experiment in which the lytic activity of allogeneic and autologous cultures was assessed at days 7, 10, and 14. In IL2-supplemented cultures, CTL activity was maximal at day 7 (215 LU) and gradually decreased by day 10 (143 LU) and day 14 (62 LU) . The effect of IL7 on the CTL response was delayed in comparison with IL2 such that maximal activity (182 LU) was detected on day 10. However, the levels of peak lytic activity arising in cultures supplemented with either IL-2 or IL7 were similar. In contrast to CTL activity, optimal LAK cell activity induced by either IL2 or IL-7 was detected at day 10 (900 and 80 LU, respectively), however, at none of the time points tested did the activity induced by IL7 approach that of IL2. Dose-Response ofI1,2 and IL7 in CTL and LAK Cell Generation. The comparative efficiency of 11,2 and IL-7 in promoting the generation of both CTL and LAK cells was examined by culturing PBMC in MLC or autologous cultures with varying doses of cytokine and testing for lytic activity 12 d later. Table 4 shows that 11,2 enhanced CTL generation when present at concentrations >1 ng/ml. In contrast, >10 ng/ml of 11,7 was required for a similar effect . However, in terms of total lytic activity generated, IL-7 was at least as effective as IL2 when present at 10 and 100 ng/ml, although it should be noted that the day of assay (day 12) was more optimal for detection of 11,7 effects than IL-2 effects (Table  3) . Notably, both IL-2 and IL7 enhanced cell recovery to a similar degree in allogeneic cultures . Cells were also stimulated to proliferate by both cytokines in autologous cultures, but to a lesser extent than in allogeneic cultures. The addition of 1 ng/ml or more of either IL-2 or IL-7 to autologous cultures resulted in the development of significant cytotoxic activity against either Daudi (NK-insensitive) or K562 (NKsensitive) target cells. However, in contrast to the similar effects of these cytokines on CTL induction, IL-2 was far more potent than IL-7 at inducing LAK cells in terms of the maximal amount of lytic activity generated per culture.
Induction ofProliferation by 11,7 Is Independent ofIL2. As IL-2 is a potent inducer of both CTL and LAK cells, the effects of IL-7 on cytolytic cells could conceivably be mediated via the secondary production of IL2. To address this possibility, we assessed the effects of an IL2-neutralizing antiserum on the induction of cell proliferation, CTL, and LAK cells by 11,7. The anti-IL-2 serum was a potent inhibitor of the proliferative response in IL2-supplemented VB anti-KB cultures, causing total ablation of [3H]thymidine incorporation induced by 10 ng/ml of IL-2 ( Fig. 3) . High concentrations of IL2 (100 ng/ml) could overcome the inhibitory effects of the anti-IL2 serum, suggesting the serum itself was not toxic. In contrast, the induction of proliferation by IL-7 was virtually unaffected by the presence of anti-11,2, implying that under these culture conditions IL-7-mediated proliferation is independent of IL2.
Effects ofAnti-IL2 on the Induction ofCTL and LAK Cells by either 11,2 or IL7. Fig. 4 shows that the anti-IL2 serum inhibited substantially, but not totally, the effect of IL-7 on the generation of CTL in MLC, reducing the lytic activity from 88 LU per culture to 8 LU. In contrast, anti-IL-2 had a limited effect on the induction of LAK cell activity by IL7, reducing LU from 28 to 20. Similar results were obtained if the cultures were assayed at either day 10 or day 14. In control cultures, the anti=IL2 serum inhibited the IL-2-mediated induction ofboth LAK cells and CTL to background levels . Interestingly, lytic activity that developed in the absence of exogenously added cytokine was also suppressed by anti-IL-2, suggesting that endogenously produced IL-2 is responsible for such activity in these cultures . In addition, IL-7-mediated induction of CTL and LAK cells was not significantly affected by neutralizing antibodies against either 11,4 or I1r6 (data not shown) . MLC is delayed until day 3 or 4, it has activity equivalent to IL-2 (15). The combination of IL-2 and IL-7 had virtually identical effects on the generation ofboth populations of cytolytic cells as IL2 acting alone. The patterns ofresponsiveness observed at day 14 assay (data not shown) were essentially similar to those observed at day 7 (Table 5 ). In addition, varying the doses ofIL-2 and IL7 resulted in no evidence for synergy between these two cytokines for either CTL enhancement or LAK cell induction (data not shown) .
Characterization ofEffector Cells Mediating CTL and LAK Activity. Experiments Interleukin 7 Regulation of Human Cytolytic Lymphocytes to the cells, or cell damage due to scraping. Among CTL generated in the presence of either 11,2 or IIs7, the vast majority of lytic activity was contained within the CD8+ population with no activity within the CD4+ cells. Among
Values represent mean of two experiments . " VB cells were incubated with irradiated KB cells in the presence of various cytokines (used at 10 ng/ml) . Lytic activity against s1 Crlabeled PHA blasts from donor KB was assessed on day 7. t VB cells were incubated with irradiated autologous filler cells and assessed for the ability to lyse s1 Cr-labeled Daudi targets on day 7. the IIT2-stimulated cells, the CD56+ population contained a significant, though small, amount of lytic activity (42 LU), whereas CD56+ cells from IIr7-supplemented cultures had very weak lytic activity (4 .4 LU) .
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To examine the cell surface phenotype of LAK cells, effector cells were divided into CD8 -and CD8+, CD56 -and CD56+, or y/6 -and y/S+ subsets, and assessed for lytic activity against Daudi targets ( Table 7) . As previously de-VB PBMC were cultured with irradiated VB filler cells and supplemented with either IL-2 or IL-7 . Cells were cultured for 8 d before separating into subpopulations of cells by immunoadsorbent panning and assaying for lytic activity against Daudi targets . scribed (24) (25) (26) (27) (28) (29) (30) , LAK effector cells were phenotypically heterogeneous. LAK cells stimulated by either I1r2 or IL7 were comprised of CD8+, as well as CD56+ and y/S+ cells. Unlike CTL effector cells, greater lytic activity was found in the CD8`than in the CD8+ cells . The most potently lytic cells on a per cell basis were the CD56+ cells, which were 10-fold more lytic than their CD56 -counterparts . Cells expressing the TCRy/6 also exhibited significant lytic activity on a per cell basis, though their overall contribution to the total lytic activity was small due to their low numbers. Thus, the cell surface phenotype of LAK cells induced by 11,2 or 11,7 was similar, with IL-2 inducing 10-fold greater lytic activity in all cell populations tested . Quantitation ofAlloreactive CTLP and Autologous LAKP Frequencies in Limiting Dilution Cultures Supplemented with II, 2, IL4, or IL7. In these experiments, we wished to examine directly the frequency of cytolytic progenitor cells from PBMC that could respond to various cytokines . To this end, limiting dilution cultures were established to allow estimation of the frequency ofCTLP and LAK-P under conditions where IL2, IT-4, or IL7 was used as a culture supplement to promote cellular activation and/or expansion . Limiting numbers of VB-responding cells were cultured in the presence of 105 irradiated KB or VB cells and IL2, 114, or IL7 at 10 ng/ml. After 13 or 14 d, microcultures were assessed for the ability to lyse "Cr-labeled KB PHA blasts (allogeneic cultures) or Daudi targets (autologous cultures) . As shown in Table 8 , nearly equivalent frequencies of CTLP were detected in allogeneic limiting dilution cultures supplemented with IL-2, IL4, or IL7 (1:882 to 1:5,486), with IL4 activating a slightly lower frequency than either IL-2 or IL7 . In contrast, the frequency of CTLP detected in noncytokine-supplemented cultures ranged from 1:75,000 to <1:240,000. Fig. 5 shows the percent specific "Cr release exhibited by the 24 individual replicate microcultures at each of the responding cell concentrations from experiment 1 ( Table 8) . Based upon the assumptions that lytic activity depends on both the number of cytolytic cells present in culture and the average lytic ac- tivity on a per cell basis, an average clone size can be estimated from the data in Fig. 5 . The average clone size was calculated by dividing the sum of the percent specific 5'Cr release for the positive wells from each experimental group by the total number of clones per group (calculated from the Poisson equation) . The average size of CTL clones in limiting dilution cultures stimulated with 11,4 or IL7 was similar (11 .6 and 10.4% specific lysis) . The average clone size calculated for I1,2-supplemented cultures was somewhat greater (19.2% specific lysis) . In contrast to CTLP, the frequency of LAK-P responsive to the three cytokines differed markedly. IL2 induced 1:53 to 1:395 PBMC to give rise to cells that could lyse Daudi targets. 11,7 induced fivefold fewer LAK P than 11,2. 11,4 was the weakest of the cytokines tested in this regard, inducing 220-fold fewer LAK-P than IL2. Furthermore, only very weak cytolytic activity was demonstrable among cytolytically positive microcultures arising in IL4 compared with either 11,2 or 11,7 (Fig. 5) . Thus, IL-2 and IL7 induced an equivalent average LAK clone size (13.2 and 12.8% specific 5'Cr release, respectively), which far exceeded the average of the few clones induced by 11,4 (3.2% specific 5'Cr release).
The addition of anti-11,2 serum to IL2-and 11,7-stimulated limiting dilution cultures (Table 8, Exp . 3 and 4) had effects similar to those seen in bulk cultures. Anti-IL-2 reduced the frequency of both CTLP and LAKP detected in IL2-supplemented cultures to background (medium alone) levels . In contrast, anti-11,2 reduced the frequency of CTLP detected in the presence of IL7 only two-fold, and had virtually no effect on the frequency of LAK-P responsive to IL7.
Discussion
Recently it was reported that 11,7, described originally as a pre-B cell growth factor, is also a potent costimulus for the growth of both murine and human CD4+ and CD8+ T cells (10-13). In the experiments reported here, we investigated the effect of rIL7 on the generation ofCTL and LAK Limiting numbers of VB responder cells were cultured with irradiated KB cells (CTL-P) or VB cells (LAK-P) and IL-2, IL-4, or IL-7 at 10 ng/ml. Results are expressed as frequency of precursor cells cytolytic for either KB PHA blasts (CTL-P) or Daudi targets (LAK-P) when tested at day 13 or 14 . " Experiment number .
CTL-P LAK-P Limit dilution cultures were established as described for cells from human peripheral blood . When IT-,7 was added to MLC, it was found to enhance the generation of antigenspecific CTL activity with potency similar to IIT2. Although the two rytokines induced equivalent levels of lytic activity, optimal CTL enhancement by IL7 occurred at a later time in culture than noted for IL2 (day 10 vs. 7) . IL-7 was also found to induce LAK cells in the absence of overt antigen, but with substantially less potency than IL2. Given the known ability of IL2 to promote T cell growth and differentiation, an obvious and important consideration in the present studies concerns the role of IL2 as the actual mediator of 11,7 effects . This possibility is particularly relevant in view of the recent demonstration that IL7 induces the p55 chain of the IL2R on murine and human T cells (11, 12) . To address this issue, an antiserum against human IL-2 was used in culture in conjunction with IL-7. The anti-11,2 serum had virtually no effect on the enhancement of cell 585 Alderson et al .
proliferation induced by IL7 in MLC, implying that this activity of IL7 is independent of IL2 . However, the effect of 11,7 on CTL induction in MLC was found to be partially inhibitable by the anti-L2 serum, suggesting that IL2 plays a secondary role in these cultures. This finding is not surprising in view of the fact that endogenous IL-2 is typically produced when T cells are confronted with an antigenic stimulus, as they are in MLC. Indeed, the fact that the anti-IL2 serum reduced endogenous cell proliferation and both CTL and LAK formation in the absence of added cytokine suggests that low amounts of IL2 are produced in these cultures. However, assay of culture supernatants for the presence of IL2 by the CTLL assay (20) failed to reveal higher levels of IL-2 in IL-7-supplemented cultures when compared with nonsupplemented cultures (data not shown) . These results suggest that IL7 does not directly induce IL-2 production . Furthermore, no synergy was observed between exogenous IL-2 and IL7 in CTL induction (Table 5) , and no enhanced response to IL-2 was observed in MLC pre-cultured with IL7 for 3 d when compared with cells obtained from pre-culture with medium alone (data not shown) . In any event, the fact that enhancement of CTL generation by IL-7 was only partially inhibited by the IL-2-neutralizing agent suggests that IL7 delivers a direct proliferative and/or differentiative signal to at least some T cells . Alternatively, secondary effects of rytokines other than IL2 may contribute to the results. In this regard, neutralizing antibodies against either IL4 or IL-6 were unable to inhibit the augmentation of CTL or induction of LAK cells by IL7 (data not shown) .
It is of interest that anti-IL-2 had virtually no effect on cell proliferation in response to IL7, despite its effects on CTL formation . These results are consistent with the possibility that IL-2 or other rytokines may be responsible for the differentiation and acquisition of cytolytic activity of some IL-7-responsive cells.
In contrast to its effects on CTL generation, IL-7 was shown to induce LAK cells in a largely IL-2-independent manner. IL-7 thus joins I1r5 and IL-6 as cytokines that have recently been shown to augment non-MHC-restricted killing by either NK or LAK cells (31, 32) . However, both IL-5 and IL-6, unlike IL7, appear to be dependent upon either exogenous or endogenous IL2 for their activity on LAK or NK cells.
Considering the similar activities of IL2 and IL-7 in promoting the generation of CTL and LAK cells, it was of interest to compare the surface antigen phenotype of the effector cells mediating these two types of cytolysis. CTL generated in the presence of either IL2 or IL-7 were almost exclusively CD8+ cells, with a small contribution by CD56+ (Leu-19+) cells in IL-2-stimulated cultures and almost negligible contribution by CD56+ cells in IL-7-stimulated cultures. Precursors of LAK cells have been shown to be comprised of several cell types, predominantly CD56+ NK cells and CD56+ T cells (24, 25) . More recently, T cells expressing the TCR-y/S have been implicated in non-MHCrestricted killing of NK and LAK cell targets (26-28) . We found that effector cell populations stimulated by 11,2 or IL-7 and enriched for the expression of CD8 or CD56 or TCR-, y/b were all able to mediate lysis of LAK-sensitive Daudi targets. However, similar to previous reports (24, 25) , the majority of lytic activity on a per cell basis was found within the CD56+ population. In all the subpopulations of effector cells tested, the lytic activity ofIL7-stimulated cells was -10-fold less than in IL2-stimulated cells . Thus, 11,7 appears to act on the same lineages of cytolytic cells as IL-2, though in the case of LAK cells with far less potency.
Limiting dilution analysis in which IL-2, IL-4, or IL-7 were used to promote activation and clonal expansion revealed that these three cytokines stimulated outgrowth of approximately equivalent frequencies ofCTLP in allogeneic cultures. Clone size estimates revealed that IL-2 induced CTL clones with a somewhat greater average lytic activity than either IL4 or IL7. Our results confirm and extend those of Paliard et al. (29) , who reported similar cloning efficiencies for human T cells in either IL2 or IL-4. It is of interest that, at the bulk culture level, IL4 is as effective as IL-2 in promoting CTL generation if added late to culture but is far less effective when added at the initiation of culture (Table 5 and reference 15). The results demonstrating almost equal efficiency of11,2 and IL4 in promoting clonal expansion of CTLP in limiting dilution cultures suggest that there is no requirement for delayed addition of 11,4 when responding cell numbers are limiting. Alternatively, IL-4 may activate an infrequent, inhibitory cell type in bulk cultures that is not represented in limiting dilu-
